THOMPSON KIMBERLY KRAIG (CEO, CFO) sold 0.0% of their position (40K shares) of KRAIG BIOCRAFT LABORATORIES, INC. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 2 sales
Filed: 5/19/2022ACC: 0001493152-22-014493
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
-40K
Net shares
Net seller
$0.00
Total acquired
2
Open market trades
0B · 2S
2
Total transactions
40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−20K
Price / share
—
Trade value
—
% of position
0.0%
5/17/2022
202.92M→202.90M
Common Stock
Direct
Shares
−20K
Price / share
—
Trade value
—
% of position
0.0%
5/18/2022
202.90M→202.88M
Total
Net shares
−40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/17/2022 | S · Sale | −20K | — | — | 0.0% | 202.92M | 202.90M |
| Common Stock Direct | 5/18/2022 | S · Sale | −20K | — | — | 0.0% | 202.90M | 202.88M |
| Total | −40K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported